Profile
James Hackworth is the founder of Park Therapeutics, Inc. He currently holds director positions at Elysium Therapeutics, Inc. and Vast Therapeutics, Inc.
James Hackworth active positions
Companies | Position | Start |
---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Director/Board Member | - |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vast Therapeutics, Inc. operates as a preclinical-stage pharmaceutical company. The company was founded in 2017 and is headquartered in Durham, UT. | Director/Board Member | - |
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Tris Pharma, Inc., Park Therapeutics, Inc. develops drugs for the treatment of pain. The company is based in Morristown, NJ. The company was founded by Marc L. Lesnick, James Hackworth. James Hackworth has been the CEO since incorporation. Park Therapeutics was acquired by Tris Pharma, Inc. on April 29, 2021. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vast Therapeutics, Inc. operates as a preclinical-stage pharmaceutical company. The company was founded in 2017 and is headquartered in Durham, UT. | Health Technology |
Park Therapeutics, Inc.
Park Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Tris Pharma, Inc., Park Therapeutics, Inc. develops drugs for the treatment of pain. The company is based in Morristown, NJ. The company was founded by Marc L. Lesnick, James Hackworth. James Hackworth has been the CEO since incorporation. Park Therapeutics was acquired by Tris Pharma, Inc. on April 29, 2021. | Health Technology |
- Stock Market
- Insiders
- James Hackworth